Med Page Today
OCTOBER 30, 2024
(MedPage Today) -- Most patients should not stop taking GLP-1 receptor agonists prior to elective surgery, according to updated guidance from several medical societies, including the American Society of Anesthesiologists (ASA). This recommendation.
Medical Xpress - Cardiology
OCTOBER 30, 2024
Alternating between sitting and standing at work decreases sedentary behavior, but it has no effect on lowering blood pressure, according to a study led by a West Virginia University epidemiologist. Researchers also found that too much standing during work may have negative effects on cardiovascular health.
Med Page Today
OCTOBER 30, 2024
(MedPage Today) -- Any cardiovascular protection from colchicine in heart attack survivors seemed to be debunked with a better-powered randomized trial, researchers found. Between acute MI patients randomized to colchicine or placebo right after.
Science Daily - Heart Disease
OCTOBER 30, 2024
Chronic, low-level lead poisoning is a major risk factor for cardiovascular disease in adults and cognitive deficits in children, even at levels previously thought to be safe, Low-level lead poisoning is a risk factor for preterm. Annually 5.5 million deaths from cardiovascular disease attributed to low-level lead poisoning; accounts for a loss of 765 million IQ points in children.
Med Page Today
OCTOBER 30, 2024
(MedPage Today) -- For adolescents, weight loss after bariatric surgery was durable out to 10 years, data from the Teen Longitudinal Assessment of Bariatric Surgery (Teen-LABS) study confirmed. Among 260 adolescents who underwent bariatric surgery.
Science Daily - Heart Disease
OCTOBER 30, 2024
New research suggests older adults wait 3-6 months after a heart attack before elective noncardiac surgery to reduce the risk of serious complications like stroke or another heart attack.
Becker's Hospital Review - Cardiology
OCTOBER 30, 2024
Healthgrades published its 2025 Specialty Excellence Awards recipients Oct. 22. Of those recipients, 50 hospitals were recognized for delivering superior clinical outcomes in vascular surgery.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
Medical Xpress - Cardiology
OCTOBER 30, 2024
A heart attack can trigger a desire to get more sleep, allowing the heart to heal and reduce inflammation—and this happens because the heart sends special signals to the brain, according to a new Mount Sinai study.
HCPLive
OCTOBER 30, 2024
A retrospective review of a community-based practice provides insights into navigating setbacks in IBD care initiation due to insurance requirements.
Cardiometabolic Health Congress
OCTOBER 30, 2024
November is National Diabetes Month , and with the increasing overlap between type 2 diabetes (T2D) and metabolic dysfunction-associated steatohepatitis (MASH) , it’s critical to focus on integrating liver health into the management of cardiometabolic patients. This two-part series breaks down key treatment approaches for MASH, helping healthcare providers stay informed and deliver evidence-based care.
Dr. Smith's ECG Blog
OCTOBER 30, 2024
Smith Introduction: Saddleback ST Elevation is often an OMI mimic, so one needs to scrutinize these ECGs!! Written by Magnus Nossen Below are ECGs from six different patients. All of the patients contacted EMS due to acute onset chest pain. Imagine you get these ECGs in real time and you are asked whether or not the cath lab should be activated? All ECGs in this case have saddleback ST elevation.
HCPLive
OCTOBER 30, 2024
Dellon reviews phase 3 data supporting the 48-week safety and efficacy of cendakimab for treating EoE.
The New England Journal of Medicine
OCTOBER 30, 2024
A 69-year-old man with a history of MI and cardiomyopathy presented with 2 days of dyspnea. Regular tachycardia (124 beats per min), diaphoresis, and rales were present. A diagnosis was made.
Medical Xpress - Cardiology
OCTOBER 30, 2024
After a heart attack, aging adults face double or triple the risk of life-threatening complications—like a debilitating stroke or another heart attack—when they move forward with elective noncardiac surgeries too soon, according to new University of Rochester research published in JAMA Surgery.
The New England Journal of Medicine
OCTOBER 30, 2024
Every year, thousands of lives are saved with cardiopulmonary resuscitation (CPR). Yet, overall survival among patients with out-of-hospital cardiac arrest is approximately 10%, even in well-performing emergency medical systems. The interventions that are undertaken at the scene of a cardiac arrest are the most likely interventions to improve outcomes: early.
Science Daily - Heart Disease
OCTOBER 30, 2024
The advanced drug testing system screens multiple potential therapies simultaneously in beating heart cells.
CardiacWire
OCTOBER 30, 2024
We’re dedicating today’s top story to the people and publications that we rely on to find the most interesting cardiology stories from across the web. Assuming that you already subscribe to Cardiac Wire , these are the 40 other newsletters, websites, and social media stars to follow if you want to keep up with the latest and greatest in cardiology. I’ll always check the mainstream cardiology news websites ( TCTMD , Medscape , et al.) and the major cardiovascular journals ( JACC , AHA , JAMA Card
Medical Xpress - Cardiology
OCTOBER 30, 2024
Hypertension is the most common cardiovascular disease (CVD) comorbidity seen among dialysis patients globally, according to a study presented at Kidney Week, the annual meeting of the American Society of Nephrology, held from Oct. 23 to 27 in San Diego.
Becker's Hospital Review - Cardiology
OCTOBER 30, 2024
A federal court has dismissed an antitrust lawsuit filed against Indianapolis based-Indiana University Health. The lawsuit was filed by vascular surgeon Ricardo Vasquez, MD, who alleged the health system engaged in anti-competitive behavior.
HCPLive
OCTOBER 30, 2024
Iyer reviews findings from subgroup analyses of the phase 3 STARS study of apraglutide for SBS-IF based on demographics and disease characteristics.
American College of Cardiology
OCTOBER 30, 2024
In this week’s View, Dr. Eagle looks at the consequences of discontinuing long-term drug treatment in patients with heart failure and reduced ejection fraction (HFrEF). He then explores the effect of race and sacubitril/valsartan use in HF patients documented in a pooled analysis of the PARADIGM-HF and PARAGON-HF trials.
HCPLive
OCTOBER 30, 2024
A decade after bariatric surgery, most teens maintained weight loss and reduced obesity-related conditions such as type 2 diabetes and hypertension.
American College of Cardiology
OCTOBER 30, 2024
Several abstracts presented at TCT 2024, taking place Oct. 27-30 in Washington, DC, used data from ACC’s CathPCI Registry, Chest Pain – MI Registry and the STS/ACC TVT Registry to evaluate institutional volume and failure to rescue in TAVR, outcomes of sequential TAVR and mitral transcatheter edge-to-edge repair (TEER), the impact of coronary artery disease (CAD) and revascularization on health status and more.
Medical Xpress - Cardiology
OCTOBER 30, 2024
The largest trial to examine the impact of colchicine in acute myocardial infarction (MI) found that both acute and long-term colchicine use did not reduce cardiovascular death, myocardial infarction, stroke, or ischemia-driven revascularization.
DAIC
OCTOBER 30, 2024
tim.hodson Wed, 10/30/2024 - 13:42 Oct. 24, 2024 — Medtronic plc has announced United States Food and Drug Administration (FDA) approval of the Affera Mapping and Ablation System with Sphere-9 Catheter, an all-in-one, high-density (HD) mapping and pulsed field (PF) and radiofrequency (RF) ablation catheter for treatment of persistent atrial fibrillation (AFib) and for RF ablation of cavotricuspid isthmus (CTI) dependent atrial flutter.
Medical Xpress - Cardiology
OCTOBER 30, 2024
There are small but important differences in risk for some clinical outcomes associated with rosuvastatin and atorvastatin, according to a study published online Oct. 29 in Annals of Internal Medicine.
DAIC
OCTOBER 30, 2024
Data confirm the use of FFR CT and Plaque Analysis helps assess long-term risks, informing more personalized and effective treatment plans for patients with coronary artery disease. tim.hodson Wed, 10/30/2024 - 11:23 Oct. 27, 2024 — HeartFlow, Inc. recently announced seven-year data confirming the use of HeartFlow’s AI-enabled fractional flow reserve computed tomography (FFR CT ) and Plaque Analysis in the assessment of long-term risk of coronary artery disease (CAD) in clinically stable, symp
Medical Xpress - Cardiology
OCTOBER 30, 2024
Doctors at Mayo Clinic have used a new catheter-based approach to draw out resistant pockets of infection that settle in the heart, known as right-sided infective endocarditis, without surgery. Unless treated quickly, the walled-off infections can grow, severely damaging heart valves and potentially affecting other organs as well. In a recent study, over 90% of the participants had their infection cleared, and they had lower in-hospital mortality compared to those whose infections remained.
CTVS
OCTOBER 30, 2024
Research shows that in recent years almost half of all adults in the United States have been living with heart disease, one of the most prominent forms of vascular disease. Vascular disease affects the body’s vast network of blood vessels, veins and arteries.
Medical Xpress - Cardiology
OCTOBER 30, 2024
Findings from the first international randomized controlled trial to compare patient outcomes following treatment with large-bore mechanical thrombectomy (LBMT) versus catheter-directed thrombolysis (CDT) for intermediate-risk pulmonary embolism (PE) show that LBMT is superior with respect to the hierarchically-tested aggregated outcome of all-cause mortality, intracranial hemorrhage, major bleeding, clinical deterioration and/or escalation to bailout therapy, and postprocedural ICU admission an
HCPLive
OCTOBER 30, 2024
This interview at the Fall Clinical Dermatology Conference features a discussion with Stein Gold regarding the open-label extension of the phase 3 ADORING trial regarding tapinarof.
Open Heart
OCTOBER 30, 2024
Background Obstructive sleep apnoea (OSA) can cause left atrial (LA) and left ventricular (LV) remodelling, which is linked to atrial fibrillation (AF). Whether continuous positive airway pressure (CPAP) can reverse LA and LV remodelling in patients with OSA and paroxysmal AF (PAF) has yet to be studied. We assessed the impact of CPAP treatment on LA and LV size and function in patients with OSA and PAF before and after catheter ablation.
HCPLive
OCTOBER 30, 2024
Open-label, interim data from ASSURE shows positive effect and tolerability with once-daily seladelpar in patients with primary biliary cholangitis and compensated cirrhosis.
American College of Cardiology
OCTOBER 30, 2024
A quantitative flow ratio (QFR)-guided strategy did not provide the same prognostic benefits as a fractional flow reserve (FFR)-guided strategy for patients with intermediate coronary stenosis, based on findings from the FAVOR III Europe trial presented at TCT 2024 and simultaneously published in The Lancet.
Medical Xpress - Cardiology
OCTOBER 30, 2024
An advanced robotic system at The Hospital for Sick Children (SickKids) is changing the way physicians and scientists approach treatments for heart disease.
HCPLive
OCTOBER 30, 2024
Zand discussed the unmet need for refractory primary FSGS and the importance of investigations specifically in this population.
American College of Cardiology
OCTOBER 30, 2024
The goal of the ACURATE IDE trial was to evaluate the Acurate neo2 self-expanding valve compared with a commercially available valve (Sapien or Evolut) among patients with aortic stenosis across the risk spectrum.
Expert insights. Personalized for you.
124 
Let's personalize your content